Article Details

$16 Million Capital Raise to Progress Bionomics BNC210 PTSD Trial

Retrieved on: 2021-02-10 10:52:30

Tags for this article:

Click the tags to see associated articles and topics

$16 Million Capital Raise to Progress Bionomics BNC210 PTSD Trial. View article details on hiswai:

Excerpt

... very strong shareholder base, which includes Apeiron Investments, Biotech Value Fund, Merck, Peter Thiel and Mike Novagratz. We remain on track ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up